Peter J. Casterella

Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention

Steven R. Steinhubl, J. David Talley, Gregory A. Braden et al. · Circulation · 2001 · 359 citations

Medicine, Cardiology, Pharmacology +17

Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: Results of the coronary revascularization using integrilin and single bolus enoxaparin study

Deepak L. Bhatt, Benjamin I. Lee, Peter J. Casterella et al. · Journal of the American College of Cardiology · 2002 · 100 citations

Medicine, Cardiology, Pharmacology +15

Ionic Low-Osmolar Versus Nonionic Iso-Osmolar Contrast Media to Obviate Worsening Nephropathy After Angioplasty in Chronic Renal Failure Patients

Roxana Mehran, Eugenia Nikolsky, Ajay J. Kirtane et al. · JACC: Cardiovascular Interventions · 2009 · 70 citations

Medicine, Nephrology, Radiology +12

Restenosis after angioplasty

Mehran Moussavian, Peter J. Casterella, Paul S. Teirstein · Current Treatment Options in Cardiovascular Medicine · 2001 · 23 citations

One‐year results of the <scp>ICON</scp> (ionic versus non‐ionic contrast to obviate worsening nephropathy after angioplasty in chronic renal failure patients) Study

Gennaro Giustino, Usman Baber, Ioannis Mastoris et al. · Catheterization and Cardiovascular Interventions · 2015 · 11 citations

Medicine, Cardiology, Internal Medicine +15